Life Science Company
Novozymes A/S has acquired 10 companies, including 3 in the last 5 years.
Novozymes A/S’s largest acquisition to date was in 2010, when it acquired EMD/Merck Crop BioScience for $275M. Novozymes A/S has acquired in 4 different US states, and 7 countries. The Company’s most targeted sectors include life science (60%) and medical products (20%).
Join Mergr and gain access to Novozymes A/S’s M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the life science sector.
M&A Summary
-
M&A Total Activity10
- M&A Buy Activity10
- Total Sectors Invested 4
- Total Countries Invested 7
- M&A Buy/Sell Connections 2
- M&A Advisors 2
Unlimited Searches
